Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Xenetic Biosciences postponed its 2025 annual meeting to allow more time for reviewing shareholder proposals and governance issues.
Xenetic Biosciences has adjourned its 2025 annual meeting to a later date, citing the need for additional time to address shareholder proposals and ensure proper review of governance matters.
The company did not specify the new date or reasons for the delay beyond procedural considerations.
The adjournment allows more time for shareholder engagement and compliance with regulatory requirements.
17 Articles
Xenetic Biosciences pospuso su reunión anual de 2025 para permitir más tiempo para revisar las propuestas de los accionistas y las cuestiones de gobernanza.